Lymphogranuloma venereum

Summary

Lymphogranuloma venereum (MONDO:0005834) is a disease. A subtype of chlamydia trachomatis infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	lymphogranuloma venereum
Mondo ID	MONDO:0005834
EFO	EFO:0007353
MeSH	D008219
DOID	DOID:13819
ICD-10-CM	A55
NCIT	C26822
SNOMED CT	186946009
UMLS	C0024286
MedGen	44221
Anatomy (UBERON)	UBERON:0002391
Is cancer (heuristic)	no

Also known as: climatic or tropical bubo · Durand-Nicolas-Favre disease · LGV · lymph granuloma inguinale · lymphogranuloma inguinale

Disease family

This is a subtype of chlamydia trachomatis infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › commensal bacterial infectious disease › chlamydia trachomatis infectious disease › lymphogranuloma venereum

Related subtypes (3): trachoma, inclusion conjunctivitis, pneumonia caused by chlamydia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.